Showing 1,401 - 1,420 results of 228,073 for search '(( 5 ((mm decrease) OR (we decrease)) ) OR ( a ((mean decrease) OR (a decrease)) ))', query time: 1.82s Refine Results
  1. 1401

    CNP decrease the number of cristae in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…Transmission electron microscopy for cristae quantification was performed as described in the Methods section. CNP significantly decreased the number of cristae in the mitochondrial inner membrane in A375 cells. …”
  2. 1402
  3. 1403

    Nampt inhibition leads to decrease in Rev-erb alpha expression and glucagon secretion in alphaTC1-9 cells and pancreatic alpha cells. by Elaine Vieira (174928)

    Published 2013
    “…<p>(<b>A</b>) <i>Sirt1</i> gene expression in alphaTC1-9 cells treated with 0.5 mM, 11 mM glucose or 500 nM FK 866 for 6 hours (n = 7). …”
  4. 1404
  5. 1405

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”
  6. 1406
  7. 1407

    Effects of decreased cellulose on cell wall thickness. by Takumi Higaki (87635)

    Published 2016
    “…<p>(a) Transmission electron microscopic images of the cotyledon lateral cell wall in an <i>rsw2/kor1</i> mutant, in which cellulose production is decreased. …”
  8. 1408
  9. 1409

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  10. 1410
  11. 1411

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”
  12. 1412
  13. 1413
  14. 1414
  15. 1415
  16. 1416
  17. 1417
  18. 1418
  19. 1419
  20. 1420